Undervalued Stocks in the S&P 500 Composite Index February 2025

February 03, 2025

S&P 500 Composite Index

The Standard and Poor's 500 (S&P 500) is a stock market index tracking the stock performance of 500 of the largest companies listed on the NYSE and the Nasdaq in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued stocks in the S&P 500 Composite Index

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
EL Estee Lauder Cos 83.43 182.79 119.09 3218645 30001 2.79 149.0
ALB Albemarle 84.19 165.92 97.08 2182208 9895 1.91 0.0
MRNA Moderna 39.42 76.91 95.10 12595702 15729 0.00 0.0
BA Boeing 176.52 333.71 89.05 8760421 114244 0.00 0.0
DG Dollar Gen 71.06 120.46 69.53 3564069 15633 3.32 11.7
EPAM EPAM Sys 253.96 429.48 69.11 517021 14584 0.00 33.0
HRL Hormel Foods 29.98 48.71 62.48 2822598 16454 3.79 20.4
BIIB Biogen 143.93 226.73 57.53 1288416 21028 0.00 13.0
EIX Edison Intl 54.00 81.46 50.85 7367323 21060 5.87 15.8
OXY Occidental Petroleum 46.65 70.28 50.66 9860079 45516 1.89 12.8
All data provided as at market close January 30, 2025.

Company Details

Estee Lauder Cos

EL:NYS

Close Price

83.43

Our Valuation

182.79

% Difference

119.09

Market Cap ($M)

30001

P/E Ratio

149.0

Estee Lauder is a leader in the global prestige beauty market, participating across skin care (51% of fiscal 2024 sales), makeup (29%), fragrance (16%), and hair care (4%) categories, with top-selling brands such as Estee Lauder, Clinique, M.A.C, La Mer, Jo Malone London, Aveda, Bobbi Brown, and Origins. The firm operates in more than 150 countries, generating 30% of revenue from the Americas, 39% from Europe, the Middle East and Africa (including travel retail), and 31% from Asia-Pacific.

Access the stockcalc valuation


Albemarle

ALB:NYS

Close Price

84.19

Our Valuation

165.92

% Difference

97.08

Market Cap ($M)

9895

P/E Ratio

0.0

Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China.

Access the stockcalc valuation


Moderna

MRNA:NAS

Close Price

39.42

Our Valuation

76.91

% Difference

95.10

Market Cap ($M)

15729

P/E Ratio

0.0

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Access the stockcalc valuation


Boeing

BA:NYS

Close Price

176.52

Our Valuation

333.71

% Difference

89.05

Market Cap ($M)

114244

P/E Ratio

0.0

Boeing is a major aerospace and defense firm. It operates in three segments: commercial airplanes; defense, space, and security; and global services. Boeing's commercial airplanes segment competes with Airbus in the production of aircraft that can carry more than 130 passengers. Boeing's defense, space, and security segment competes with defense contractors such as Lockheed and Northrop to create military aircraft, satellites, and weaponry.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Dollar Gen

DG:NYS

Close Price

71.06

Our Valuation

120.46

% Difference

69.53

Market Cap ($M)

15633

P/E Ratio

11.7

With more than 20,000 locations, Dollar General's banner is nearly ubiquitous across the rural United States. Dollar General serves as a convenient shopping destination for fill-in store trips, with its value proposition most relevant to consumers in small communities with a dearth of shopping options.

Access the stockcalc valuation


EPAM Sys

EPAM:NYS

Close Price

253.96

Our Valuation

429.48

% Difference

69.11

Market Cap ($M)

14584

P/E Ratio

33.0

EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.

Access the stockcalc valuation


Hormel Foods

HRL:NYS

Close Price

29.98

Our Valuation

48.71

% Difference

62.48

Market Cap ($M)

16454

P/E Ratio

20.4

Historically meat-focused, Hormel Foods broadened its lineup to include other protein offerings and become a branded food company. The firm sells its wares through multiple channels, including US retail (62% of fiscal 2024 sales), US food service (32%), and international (6%). By product, 72% of fiscal 2024 sales were from perishable food and 28% from shelf-stable. Major brands include Hormel, Spam, Jennie-O, Columbus, Applegate, Planters, and Skippy.

Access the stockcalc valuation


Biogen

BIIB:NAS

Close Price

143.93

Our Valuation

226.73

% Difference

57.53

Market Cap ($M)

21028

P/E Ratio

13.0

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a collaboration with Roche. Biogen markets several multiple sclerosis drugs including Plegridy, Tysabri, Tecfidera, and Vumerity.

Access the stockcalc valuation


Edison Intl

EIX:NYS

Close Price

54.00

Our Valuation

81.46

% Difference

50.85

Market Cap ($M)

21060

P/E Ratio

15.8

Edison International is the parent company of Southern California Edison, an electric utility that distributes electricity to 5 million customers in a 50,000-square-mile area of Southern California, excluding Los Angeles. Edison Energy owns interests in nonutility businesses that deal in energy-related products and services. In 2014, Edison International sold its wholesale power generation subsidiary Edison Mission Energy out of bankruptcy to NRG Energy.

Access the stockcalc valuation


Occidental Petroleum

OXY:NYS

Close Price

46.65

Our Valuation

70.28

% Difference

50.66

Market Cap ($M)

45516

P/E Ratio

12.8

Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2023, the company reported net proved reserves of nearly 4 billion barrels of oil equivalent. Net production averaged 1,234 thousand barrels of oil equivalent per day in 2023 at a ratio of roughly 50% oil and natural gas liquids and 50% natural gas.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Estee Lauder Cos and Albemarle are the most undervalued stocks on the S&P 500 Composite Index. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-stocks-in-s-p-500-composite-index-february-2025
Estee Lauder Cos $EL and Albemarle $ALB are the most undervalued stocks on the S&P 500 Composite Index. See which other companies made the list: https://www.stockcalc.com/Blog/undervalued-stocks-in-s-p-500-composite-index-february-2025
Estee Lauder Cos and Albemarle are the most undervalued stocks on the S&P 500 Composite Index. See which other companies made the list here: https://www.stockcalc.com/Blog/undervalued-stocks-in-s-p-500-composite-index-february-2025

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.